Although alterations in the microbiome have been associated with a variety of diseases, the relationships between them are poorly understood. Studying the microbiome, monitoring its changes and elucidating cause and effect relationships is a complex process, which all involve monitoring the host and bacteria’s molecular information.
Microbiome therapeutics is a developing field of medicine that targets the microbiome for various diseases – but it remains largely under-utilised. Could the microbiome be a key player in disease onset? And could lifestyle changes or targeting the microbiome be the answer to helping prevent or treat these diseases?
Our upcoming webinar series – Microbiome Sequencing ONLINE – showcases research that is uncovering the role the microbiome plays in disease and therapeutic opportunities.
**Please note: By registering for the first webinar in the series you will automatically gain access to the subsequent webinars**
Webinar 1: Understanding the role of microbiome perturbations
Wednesday 8th September at 3pm BST/ 4pm CEST/ 10am EDT
With changes to the microbiome being associated with different diseases and states, understanding the relationship between the microbiome in health and disease remains a challenge. Luckily, many technologies remain in the toolbox to understand this complex relationship.
This webinar focuses on found associations between microbiome perturbations and complex phenotypes and describes how these studies are improving our understanding of these relationships.
In Vitro Models of the Human Small Intestinal & Colonic Microbiota: Compositional and Functional Analysis – Elliot Friedman, Director of Data Integration, Penn Center for Nutritional Science & Medicine, University of Pennsylvania
Charting the unknown universe of the human gut microbiome and its relevance to health and disease– Alexandre Almeida, ESPOD fellow, EMBL-EBI
Webinar 2: Host-microbiome interactions
Wednesday 15th September at 3pm BST/ 4pm CEST/ 10am EDT
Scientists are continuing to discover microbiome perturbations in various disease states, accelerating our knowledge about the relationships between the host and bacteria’s molecular information. This webinar will showcase recent studies that have uncovered host-microbe interactions and discuss opportunities for relevant multi-omics sequencing technologies.
Ontology-based host-microbiome interaction knowledge and data standardization, integration, and analysis – Yongqun (Oliver) He, Associate Professor, University of Michigan Medical School
Confounding for technical biases and how fasting alters the microbiome and sustained Blood Pressure and Body Weight Reduction in Patients with Metabolic Syndrome – Theda Bartolomaeus, PhD Student, Forslund Lab, MDC Berlin
Webinar 3: The microbiome and intestinal health
Wednesday 22nd September at 3pm BST/ 4pm CEST/ 10am EDT
Changes in the intestinal microbiome is associated with a variety of intestinal health issues. This webinar focuses on research that defines healthy and unhealthy microbiome states and what this means for future therapeutics.
Shared and disease-specific host gene-microbiome interactions across human diseases – Sambhawa Priya, PhD Student, Blekhman lab, University of Minnesota
The microbiome of inflammatory bowel disease – Marcus Claesson, Lecturer, University College Cork
Speakers
Elliot Friedman, Director of Data Integration, Penn Center for Nutritional Science & Medicine, University of Pennsylvania
Alexandre Almeida, ESPOD fellow, EMBL-EBI
Yongqun (Oliver) He, Associate Professor, University of Michigan Medical School
Theda Bartolomaeus, PhD Student, Forslund Lab, MDC Berlin
Sambhawa Priya, PhD Student, Blekhman lab, University of Minnesota
Marcus Claesson, Lecturer, University College Cork
